The study included 1,466 patients with newly diagnosed POAG receiving care at health systems in the Sight Outcomes Research ...

Character Biosciences enhances its leadership team and secures $93 million in Series B funding to advance treatments for ...

Discover new insights into central serous chorioretinopathy, including pathophysiology, imaging techniques, and effective treatment options for better patient outcomes.

iVeena Delivery Systems has been awarded a $2 million phase 2 Small Business Innovation Research (SBIR) grant from the ...

Optos partners with Toku to integrate BioAge AI into retinal imaging devices, enhancing eye care professionals' insights into ...

Guymer discusses early intervention strategies for intermediate AMD, highlighting risk factors, and potential trial designs ...

We ask leading experts in the field what eye disease they would cure and why. In celebration of Ophthalmology Times' 50th ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Lions World Vision Institute Expands OptiGraft® CAIRS Program to Include Asymmetrical Laser-Cut CAIRS, Broadening Surgical ...

A new staging system for diabetic retinopathy and macular edema is essential, integrating advanced imaging techniques for better disease management and patient outcomes.

Kwangdong, a top 5 pharmaceutical and healthcare company in Korea, is actively involved in research and development ...

Kalaris Therapeutics initiates a phase 1b/2 study for TH103, targeting neovascular age-related macular degeneration and ...